Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.13 - $0.46 $75,104 - $265,754
-577,727 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$0.34 - $0.58 $220,861 - $376,763
-649,593 Reduced 52.93%
577,727 $264,000
Q4 2021

Feb 14, 2022

BUY
$0.54 - $2.51 $596,406 - $2.77 Million
1,104,457 Added 898.93%
1,227,320 $658,000
Q3 2021

Nov 15, 2021

SELL
$1.54 - $3.04 $96,151 - $189,805
-62,436 Reduced 33.69%
122,863 $208,000
Q2 2021

Aug 16, 2021

BUY
$2.2 - $3.2 $41,659 - $60,595
18,936 Added 11.38%
185,299 $480,000
Q1 2021

May 17, 2021

BUY
$2.08 - $5.26 $346,035 - $875,069
166,363 New
166,363 $424,000
Q4 2020

Feb 16, 2021

SELL
$1.89 - $2.48 $425,195 - $557,928
-224,971 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.7 - $7.6 $382,450 - $1.71 Million
224,971 New
224,971 $439,000

About Aditxt, Inc.


  • Ticker ADTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,161,130
  • Market Cap $749K
  • Description
  • Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...
More about ADTX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.